{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:43:42Z","timestamp":1762641822729,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.maturitas.2015.12.011","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T13:01:47Z","timestamp":1451307707000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Bone loss and wrist fractures after withdrawal of hormone therapy: The 15-year follow-up of the OSTPRE cohort"],"prefix":"10.1016","volume":"85","author":[{"given":"Jarmo","family":"Saarelainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saara","family":"Hassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risto","family":"Honkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Koivumaa-Honkanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonas","family":"Sirola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marja H.","family":"Komulainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjo","family":"Tuppurainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2015.12.011_bib0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.GME.0000148644.55486.36","article-title":"Hormone use and patient concerns after the findings of the Women\u2019s Health Initiative","volume":"4","author":"Rolnick","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2005.02.019","article-title":"Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004\/2005 position statements on peri- and postmenopausal hormone replacement therapy","volume":"1","author":"Skouby","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0015","first-page":"321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"3","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0020","doi-asserted-by":"crossref","unstructured":"Million women study collaborators endometrial cancer and hormone-replacement therapy in the million women study. Obstet. Gynecol. Surv. 9 (2005) 595\u2013597.","DOI":"10.1097\/01.ogx.0000175801.76543.74"},{"issue":"pt. 1","key":"10.1016\/j.maturitas.2015.12.011_bib0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.GME.0000123641.76105.B5","article-title":"Changes in bone density and turnover after alendronate or estrogen withdrawal","volume":"6","author":"Wasnich","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0030","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.fertnstert.2004.12.040","article-title":"Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation","volume":"6","author":"Ringa","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.fertnstert.2009.07.1001","article-title":"Discontinuation of hormone therapy in the French GAZEL cohort 1990\u20132006","volume":"4","author":"Ringa","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0040","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bone.2003.12.021","article-title":"Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study","volume":"4","author":"Bagger","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","article-title":"PEPI safety follow-up study (PSFS) investigators: bone mass response to discontinuation of long-term hormone replacement therapy: results from the postmenopausal estrogen\/progestin interventions (PEPI) safety follow-up study","volume":"6","author":"Greendale","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0050","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers","volume":"11","author":"Gallagher","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-137-11-200212030-00008","article-title":"Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial","volume":"11","author":"Greenspan","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13697130701370435","article-title":"The effects of short-term hormone replacement therapy on long-term bone mineral density","volume":"3","author":"Middleton","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S8756-3282(03)00171-6","article-title":"Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study","volume":"1","author":"Sornay-Rendu","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S8756-3282(01)00706-2","article-title":"Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women","volume":"4","author":"Neele","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10654-004-2173-y","article-title":"Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: the Danish nurse cohort study","volume":"12","author":"Hundrup","year":"2004","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0080","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.AOG.0000114986.14806.37","article-title":"Rapid loss of hip fracture protection after estrogen cessation: evidence from the National osteoporosis risk assessment","volume":"3","author":"Yates","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/aje\/kwr044","article-title":"Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort","volume":"1","author":"Engel","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0090","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/gme.0b013e31821b01c7","article-title":"Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization","volume":"11","author":"Karim","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-5122(93)90004-2","article-title":"Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women-the results of the baseline postal enquiry of the Kuopio osteoporosis risk factor and prevention study","volume":"2","author":"Tuppurainen","year":"1993","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00310160","article-title":"Bone mineral density and risk factors for osteoporosis\u2014a population-based study of 1600 perimenopausal women","volume":"1","author":"Kroger","year":"1994","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1385\/JCD:8:3:320","article-title":"Cross-calibration of lunar DPX-IQ and DPX dual-energy X-ray densitometers for bone mineral measurements in women: effect of body anthropometry","volume":"3","author":"Saarelainen","year":"2005","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/J.1524-4733.2002.55150.x","article-title":"Odds ratio, relative risk, absolute risk reduction, and the number needed to treat-which of these should we use?","volume":"5","author":"Schechtman","year":"2002","journal-title":"Value Health"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/gme.0b013e3181334b6c","article-title":"Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio osteoporosis risk factor and prevention study","volume":"2","author":"Sandini","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0120","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ijc.28167","article-title":"Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer\u2014a population-based case control study from Finland","volume":"7","author":"Koskela-Niska","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-5122(02)00341-9","article-title":"Compliance with hormone replacement therapy in Thai women","volume":"3","author":"Manonai","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.maturitas.2005.10.008","article-title":"Personal use of hormone therapy by postmenopausal women doctors and male doctors\u2019 wives in Italy after the publication of WHI trial","volume":"2","author":"Biglia","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0412.2011.01069.x","article-title":"Change in the frequency of HRT use from 2000 to 2005 and reasons to discontinue: follow-up of a normal cohort in Finland","volume":"4","author":"Jalava-Broman","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5122(03)00130-0","article-title":"Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol","volume":"2","author":"Ushiroyama","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J074v18n04_03","article-title":"Past-users of HRT are osteopenic four months after discontinuation:an observational and cross-sectional study","volume":"4","author":"Aubertin-Leheudre","year":"2006","journal-title":"J. Women Aging"},{"key":"10.1016\/j.maturitas.2015.12.011_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s001980170107","article-title":"Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women","volume":"5","author":"Tremollieres","year":"2001","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TCRM.S19385","article-title":"Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysis","author":"Fraser","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.maturitas.2015.12.011_bib0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/MI.2008.008008","article-title":"A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women","volume":"2","author":"Heikkinen","year":"2008","journal-title":"Menopause Int."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:04:41Z","timestamp":1759914281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512215300979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":32,"alternative-id":["S0378512215300979"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.12.011","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone loss and wrist fractures after withdrawal of hormone therapy: The 15-year follow-up of the OSTPRE cohort","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}